FEATURE ARTICLES
The rising incidence of mental health disorders brought the mental health benefits of psychedelics back into the spotlight, and we are currently at a watershed moment.
- July 2025 — CDMO Opportunities And Threats Report
- Gedatolisib Shatters Phase 3 Goals and Scales For Breast Cancer Breakthrough
- EMA Issues Revised Annex 11, New Annex 22, And Associated Documents On Data Governance
- Minimizing The Impact Of Human Errors Using Relational Risk Analysis
- Trends And Benefits Of Lean Manufacturing In Pharmaceutical Injectable Facilities
- Environmental Monitoring Performance Qualification In New Drug Manufacturing Facilities
- The Rise Of NAMs
PHARMA ONLINE WHITE PAPERS
-
![Scientists In Lab Working Together On Digital Tablet GettyImages-893884830]( "The Complete Guide To Immunohistochemistry")
The Complete Guide To ImmunohistochemistryImmunohistochemistry (IHC) is a tool for visualizing the distribution and localization of antigens within tissue sections. Learn about IHC sample preparation, detection and amplification systems, and more.
-
Developing Effective Procedures10/21/2024
Effective procedure development starts with understanding the purpose and should integrate change management, risk management, and knowledge management to ensure a robust quality system.
-
Enabling Digital Twins With Computational Fluid Dynamics Modeling1/16/2025
Embrace the transformative power of predictive modeling and digital twin technology to optimize bioprocess efficiency, ensure product quality, and drive innovation in biopharmaceutical manufacturing.
-
Flexible Fill/Finish Solutions To Bridge The Clinical-To-Commercial Gap7/23/2025
As biopharma complexity grows, flexible CDMOs like Afton Scientific are essential for navigating evolving fill/finish needs, accelerated timelines, and regulatory uncertainty with agility and expertise.
-
FT-IR Identifies Contaminants And Helps Avoid Hazards And Product Loss3/7/2024
Fourier Transform Infrared Spectroscopy (FT-IR) is a reliable method with multiple applications when it comes to identifying both intrinsic and extrinsic compounds in a drug product.
-
Leveraging Life Sciences Data For Intelligent Decision-Making2/18/2025
Industry 4.0 drives life sciences to prioritize data-driven decision-making by integrating advanced technologies in QMS. Discover how modern data management can improve compliance.
PHARMA ONLINE APP NOTES & CASE STUDIES
- BSL-3 Mobile Biocontainment Laboratory For Vaccine Development Research
- Merck Process Transfer And Scale-Up Of Batch Protein A
- Detection And Quantification Of Amorphous Content In Materials
- Re-Engineering A Complex Process For FDA Compliance
- Seamless Process Transfer Using An In Silico Bioreactor Scaling Tool
NEWSLETTER ARCHIVE
- 08.19.25 -- President Trump Demands MFN Prices In Manufacturer Letters
- 08.15.25 -- Ensure Quality With Process Equipment Providers
- 08.15.25 -- Audit Trail Compliance And What To Look For In Mitigation Software
- 08.14.25 -- Unlocking Value In Biopharma Operations: A C-Suite Call To Action
- 08.14.25 -- STREAM Edition: When To Think About Utilities In Facility Design
INDUSTRY NEWS
-
![Pharmaceutical factory, pills-GettyImages-1419815069]( "FDA Launches PreCheck Program")
FDA Launches PreCheck ProgramThe program introduces a two-phase approach to enable new U.S. drug manufacturing facilities: The Facility Readiness Phase and the Application Submission Phase.
-
![expensive healthcare, drug container, pills-GettyImages-171587042]( "President Trump Demands MFN Prices In Manufacturer Letters")
President Trump Demands MFN Prices In Manufacturer LettersPresident Trump has sent out a letter to 17 major pharmaceutical manufacturers, asking them to commit to lower prices by Sept. 29, 2025, or he plans to deploy every tool in his arsenal to protect American families.
-
![Bristol Myers Squibb office-GettyImages-2160008492]( "Bristol Myers Squibb Forms Immunology Company With Finance Partner")
Bristol Myers Squibb Forms Immunology Company With Finance PartnerThe NewCo pipeline will start with three clinical-stage and two phase 1-ready investigational medicines that each target mechanisms in autoimmune diseases.
-
![GettyImages-2139576234-partner-team-collaborate-collaboration-meet]( "George Tidmarsh Named CDER Director")
George Tidmarsh Named CDER DirectorTidmarsh has over 30 years of experience in biotechnology, clinical medicine, and regulatory science and has authored 143 scientific publications and patents.
-
![GettyImages-1125144281-sanofi]( "Sanofi Expands Immunology Portfolio With Blueprint Acquisition")
Sanofi Expands Immunology Portfolio With Blueprint AcquisitionSanofi expanded its portfolio in immunology with the completed acquisition of Blueprint Medicines Corporation.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
The modern microbiology laboratory is starting to look very different from the laboratory of even 10 years ago. The work will be similar, yet technology will have advanced. Automation, in particular, is taking center stage. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
Particle Measuring Systems Opens New Manufacturing & Innovation Hub To Drive Future Growth In Colorado8/19/2025
Particle Measuring Systems is proud to announce the opening of its new state-of-the-art Manufacturing & Innovation Hub, marking a major milestone in the company’s evolution and long-term growth and investment strategy. This purpose-built facility is designed to support innovation, enhance customer engagement and service delivery, and expand manufacturing capabilities—solidifying our leadership in advancing contamination-free manufacturing and sterility assurance.
-
Upperton Pharma Solutions Awarded VaxHub Sustainable Grant To Advance Oral Vaccine Delivery In Partnership With The University Of Oxford's Pandemic Sciences Institute8/18/2025
Upperton Pharma Solutions, a leading UK-based CDMO, has been awarded a grant as part of the first VaxHub Sustainable Platform Funding Call, in collaboration with the University of Oxford. The funding supports the development of an oral formulation for Adenovirus-vectored vaccines.
-
CDMO Made Scientific Opens New Cell Therapy Manufacturing Facility In New Jersey8/14/2025
Made Scientific, a leading U.S.-based cell therapy contract development and manufacturing organization (CDMO), held a ribbon-cutting ceremony yesterday to commemorate the grand opening of its new 60,000 sq. ft. GMP manufacturing facility and headquarters in Princeton, New Jersey.
-
AST Names Industry Veteran Jacob Stephen As Chief Operating Officer8/13/2025
AST is pleased to announce that Jacob Stephen will be joining the AST Team as Chief Operations Officer at the Tacoma-headquartered drug product equipment manufacturing company. Stephen joins AST from IPS, where he most recently served as Head of Operations for the Americas.
-
AbbVie Announces $195 Million Investment To Expand API Manufacturing Capacity In Chicago8/13/2025
AbbVie (NYSE: ABBV) today announced a $195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ingredient (API) production in the U.S. This expansion is part of AbbVie's previously announced commitment to invest more than $10 billion of capital in the U.S. to broadly support innovation and expand critical manufacturing capabilities and capacity.
